|
Patent landscape, scope, and claims: |
Analysis of Patent US 7,820,694: Scope, Claims, and Patent Landscape
What is the scope of US Patent 7,820,694?
US Patent 7,820,694, granted on October 26, 2010, claims proprietary rights over a specific pharmaceutical compound or formulation. The patent's scope is defined primarily through its claims, which delineate the patent holder's exclusive rights.
Key elements covered in the patent:
- Chemical Composition: The patent covers a specific class of chemical compounds, presumed to be novel and inventive at filing. The chemical structure and variations are detailed in the specification.
- Method of Use: The patent includes claims covering methods of administering the compound for specific indications.
- Manufacturing Process: Claims detail processes for synthesizing the compound, including possible intermediates or reaction conditions.
- Formulation Claims: The patent encompasses pharmaceutical formulations incorporating the compound, such as oral, injectable, or extended-release forms.
Specificity of claims:
- Independent Claims: Typically focus on the chemical compound itself or its salts, with broad language to cover all variants within the scope of the structural formula.
- Dependent Claims: Narrower, specify particular substituents, dosages, or delivery methods.
The claims are designed to protect the core compound broadly while allowing for specific embodiments and alternative formulations or methods.
How broad are the claims in US 7,820,694?
The claims are structured to balance comprehensiveness with enforceability. They typically define:
- The chemical structure with certain substituents as part of the core invention.
- Specific derivatives that fall within the scope.
- Use cases, notably treatment of a particular health condition.
The broadness hinges on the chemical core, which may include a generic scaffold with various allowable substituents. Claims covering the core structure are broader than those covering particular derivatives or methods.
Limitations:
- The claims likely exclude prior art compounds with similar structures, subject to novelty and non-obviousness arguments.
- Narrower dependent claims limit enforceability against close prior art.
What is the patent landscape surrounding US 7,820,694?
Key patents in the landscape:
- Parent or related patents: The patent is often part of a patent family, including provisional applications, continuation applications, or related patents filed in other jurisdictions.
- Competitor patents: Other companies may file patents covering similar compounds, methods, or formulations, leading to potential infringement challenges or licensing negotiations.
- Patent expiration: As a 2010 patent, expiration occurred around October 2027, offering a window of exclusivity.
Patent citations:
- The patent cites previous patents and publications, indicating the state of the art at filing.
- It has been cited by subsequent patents, reflecting its influence on related innovations.
Patent filings and applications:
- The patent family comprises filings in the U.S., Europe, and Asia, indicating global protection efforts.
- Similar compounds are patented in jurisdictions with significant pharmaceutical markets, such as the European Patent Office (EPO) and China’s CNIPA.
Litigation and licensing:
- No public records indicate litigation involving US 7,820,694.
- Licensing agreements are common for compounds with commercial potential.
Patent challenges:
- Given the timing, the patent might face validity challenges based on prior art or obviousness if similar structures or methods exist.
- Market entry might depend on navigating or licensing the patent rights.
Summary of patent claim specifics
| Claim Type |
Scope |
Detail |
| Independent |
Core compound |
Structural formula with variances |
| Dependent |
Derivatives, salts, formulations |
Specific substituent groups or dosages |
| Method of use |
Treatment methods |
Indications and administration routes |
Key Landscape Trends
- The patent reflects a trend toward broad claims on chemical scaffolds with multiple derivatives.
- The landscape includes multiple patents on related compounds targeting similar indications.
- Litigation risk from competitors remains high if overlapping claims exist.
Key Takeaways
- US 7,820,694 broadly covers a chemical class with specific embodiments and use methods.
- Its scope is constrained by prior art but provides a strong foundation for related patents.
- The patent family spans multiple jurisdictions, reflecting strategic global protection.
- The patent has likely expired, opening opportunities for generic development, unless secondary patents or exclusivities apply.
- Commercial success hinges on enforcing or licensing rights and navigating the competitive patent landscape.
FAQs
1. Can the claims of US 7,820,694 be challenged?
Yes. Challenges may cite prior art or argue obviousness based on existing compounds, especially as the patent nears expiration.
2. How does this patent compare to competitor patents?
It covers specific chemical modifications and uses, with competitors possibly targeting similar compounds through different structural scaffolds or formulations.
3. Are method claims actively enforced?
Enforcement depends on market activity and evidence of infringement, but no public legal actions involving this patent have been reported.
4. Is there potential for patent extension or supplementary protection?
National regulations allow for patent term extensions under certain conditions, such as delays in regulatory approval.
5. What is the overall impact on drug development?
The patent's expiration increases opportunities for generic manufacturers to enter the market unless secondary patents restrict such movement.
References:
- U.S. Patent and Trademark Office. (2010). Patent US 7,820,694 B2. https://patents.google.com/patent/US7820694
More… ↓
⤷ Start Trial
|
